Ontology highlight
ABSTRACT:
SUBMITTER: Pizzuti L
PROVIDER: S-EPMC5902232 | biostudies-literature | 2018 Apr
REPOSITORIES: biostudies-literature
Pizzuti Laura L Sergi Domenico D Sperduti Isabella I Lauro Luigi Di LD Mazzotta Marco M Botti Claudio C Izzo Fiorentino F Marchetti Luca L Tomao Silverio S Marchetti Paolo P Natoli Clara C Grassadonia Antonino A Gamucci Teresa T Mentuccia Lucia L Magnolfi Emanuela E Vaccaro Angela A Cassano Alessandra A Rossi Ernesto E Botticelli Andrea A Sini Valentina V Sarobba Maria G MG Fabbri Maria Agnese MA Moscetti Luca L Astone Antonio A Michelotti Andrea A De Angelis Claudia C Bertolini Ilaria I Angelini Francesco F Ciliberto Gennaro G Maugeri-Saccà Marcello M Giordano Antonio A Barba Maddalena M Vici Patrizia P
Cancer biology & therapy 20180216 4
The evidence emerged from the TOURANDOT trial encourages evaluating the role of anthropometric determinants on treatment outcomes in HER2-negative metastatic breast cancer patients treated with bevacizumab-including regimens. We thus analyzed data from a subgroup of these patients from a larger cohort previously assessed for treatment outcomes. Patients were included in the present analysis if body mass index values had been recorded at baseline. Clinical benefit rates, progression free survival ...[more]